Free Trial

3,981,965 Shares in Agilon Health, Inc. $AGL Acquired by Nuveen LLC

Agilon Health logo with Medical background

Key Points

  • Nuveen LLC has invested $17.24 million in Agilon Health, acquiring approximately 3,981,965 shares, which represent about 0.96% of the company as of the latest SEC filing.
  • Agilon Health's stock has seen varying ratings recently, with Citigroup upgrading it from "neutral" to "buy" and setting a new price target of $5.00, while Benchmark lowered its target to $1.50.
  • In its latest quarterly results, Agilon Health reported a loss of $0.25 per share, significantly missing expectations, alongside a 5.9% decline in revenue compared to the previous year.
  • Interested in Agilon Health? Here are five stocks we like better.

Nuveen LLC bought a new stake in Agilon Health, Inc. (NYSE:AGL - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,981,965 shares of the company's stock, valued at approximately $17,242,000. Nuveen LLC owned about 0.96% of Agilon Health as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Humankind Investments LLC bought a new position in Agilon Health during the fourth quarter worth $30,000. Raymond James Financial Inc. acquired a new stake in Agilon Health during the fourth quarter worth $33,000. Cerity Partners LLC acquired a new stake in Agilon Health during the fourth quarter worth $34,000. Nisa Investment Advisors LLC boosted its stake in Agilon Health by 244.9% during the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after buying an additional 6,783 shares in the last quarter. Finally, Boothbay Fund Management LLC acquired a new stake in Agilon Health during the fourth quarter worth $58,000.

Agilon Health Trading Up 3.4%

NYSE AGL traded up $0.0450 on Monday, hitting $1.3750. 6,293,092 shares of the company were exchanged, compared to its average volume of 22,393,108. The firm has a 50 day moving average of $1.84 and a two-hundred day moving average of $2.97. The company has a market cap of $569.83 million, a P/E ratio of -1.79 and a beta of 0.14. Agilon Health, Inc. has a 1-year low of $0.71 and a 1-year high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.14). The firm had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The business's revenue for the quarter was down 5.9% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.07) earnings per share. Research analysts anticipate that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently commented on AGL shares. Evercore ISI reduced their target price on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a research note on Wednesday, July 9th. Benchmark reduced their target price on shares of Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a research note on Wednesday, August 6th. Robert W. Baird reduced their target price on shares of Agilon Health from $5.00 to $1.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. The Goldman Sachs Group boosted their target price on shares of Agilon Health from $2.50 to $5.00 and gave the company a "neutral" rating in a research note on Thursday, May 8th. Finally, JMP Securities restated a "market perform" rating on shares of Agilon Health in a research note on Monday, April 28th. Four equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, Agilon Health currently has an average rating of "Hold" and an average target price of $3.07.

Get Our Latest Report on Agilon Health

About Agilon Health

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Institutional Ownership by Quarter for Agilon Health (NYSE:AGL)

Should You Invest $1,000 in Agilon Health Right Now?

Before you consider Agilon Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.

While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.